These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36632155)

  • 1. A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma.
    Ye C; Qin S; Qiu S; Zhao L; Miao J; Chen Y; Zhou T
    Transl Androl Urol; 2022 Dec; 11(12):1691-1705. PubMed ID: 36632155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
    Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A N
    Mei W; Jia X; Xin S; Liu X; Jin L; Sun X; Zhang JX; Zhang B; Yang G; Chen P; Ye L
    J Oncol; 2022; 2022():8604216. PubMed ID: 35602299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify Prostate Adenocarcinoma-Related Potential Biomarkers.
    Khorsand M; Mostafavi-Pour Z; Tahmasebi A; Omidvar Kordshouli S; Mousavi P
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2332-2355. PubMed ID: 37542606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.
    Zheng Y; Sun H; Yang S; Liu W; Jiang G
    J Cancer; 2024; 15(9):2678-2690. PubMed ID: 38577608
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a novel five-gene immune-related risk model for the prognosis evaluation of prostate adenocarcinoma patients.
    Fei H; Chen X
    Am J Cancer Res; 2022; 12(5):2337-2349. PubMed ID: 35693084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting prostate adenocarcinoma patients' survival and immune signature: a novel risk model based on telomere-related genes.
    Zheng J; Chen J; Li H; Li Y; Dong W; Jiang X
    Discov Oncol; 2024 Jun; 15(1):203. PubMed ID: 38825615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma.
    Liu J; Tan Z; Yang S; Song X; Li W
    Aging (Albany NY); 2022 Sep; 14(17):7170-7185. PubMed ID: 36103249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
    Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
    Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
    Huang ZG; He RQ; Mo ZN
    Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer.
    Mei W; Jin L; Zhang B; Sun X; Yang G; Li S; Ye L
    Front Oncol; 2022; 12():982267. PubMed ID: 36276080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma.
    Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F
    Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer.
    Chen L; Zhang M; Zhou J; Zhang L; Liang C
    Cancer Med; 2022 Nov; 11(22):4374-4388. PubMed ID: 35535438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.